Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate long-term safety and efficacy outcomes following previously administered short-term exposure to SHP607, as compared to a standard neonatal care group.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oak Hill Bio Ltd
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT06925360 · Bronchopulmonary Dysplasia
NCT06510842 · Intraventricular Hemorrhage, Lumbar Drainage, and more
NCT07205263 · Basal Ganglia Hemorrhage, Intraventricular Hemorrhage, and more
NCT07161908 · BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension
Memorial Hospital of South Bend
South Bend, Indiana
University of Mississippi Medical Center
Jackson, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions